Last update :
28/04/2024
Anticancer drug   Aldesleukin  
Injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Ilcass Argentina
Interleukina Chile
Proleukin Austria, Belgium, Brazil, Canada, Colombia, Denmark, Ecuador, France, Germany, Great Britain, Greece, Iceland, Ireland, Italy, Netherlands, Poland, Spain, Switzerland, Turkey, United Arab Emirates, United States of America, Venezuela
References   Injection   References : Aldesleukin  
Type Publication
36 Journal Alex S, Gupta SL, Minor JR, Turcovski-Corrales S, Gallelli JF, Taub D, Piscitelli SC.
Compatibility and activity of aldesleukin (recombinant interleukin-2) in presence of selected drugs during simulated Y-site administration: Evaluation of three methods.
Am J Health-Syst Pharm 1995 ; 52: 2423-2426.
3635 Manufacturer Aldesleukine (Proleukin®) - Summary of Product Characteristics
Novartis Pharmaceuticals UK Ltd 2015

  Mentions Légales